---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-017809"
form_type: "8-K"
ticker: "GOVX"
cik: "0000832489"
company_name: "GeoVax Labs, Inc."
filed_at: "2026-05-19T21:04:04+00:00"
generated_at: "2026-05-19T21:07:54.779666+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# GeoVax prices $3M private placement offering at $1.4799 per unit with warrants

## Summary
- Gross proceeds ~$3M; net proceeds ~$2.7M after placement agent fees and expenses.
- Issued 2,027,027 pre-funded warrants ($0.0001 exercise) and 4,054,054 common warrants at $1.48 exercise; Series A (5yr), Series B (18mo).
- Offering closed May 19, 2026; net proceeds used for working capital and general corporate purposes.
- Company agreed to file resale registration statement with SEC for shares underlying the warrants.
- A.G.P./Alliance Global Partners acted as sole placement agent; received 7% cash fee plus expense reimbursement.

## SEC filing metadata
- accession: 0001437749-26-017809
- form_type: 8-K
- ticker: GOVX
- cik: 0000832489
- company_name: GeoVax Labs, Inc.
- filed_at: 2026-05-19T21:04:04+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/832489/000143774926017809/0001437749-26-017809-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/832489/000143774926017809/govx20260519_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-017809
- JSON: https://secwatch.observer/filing/0001437749-26-017809.json
- Plain text: https://secwatch.observer/filing/0001437749-26-017809.txt

## Key facts
- Material Agreements
  GeoVax Labs, Inc. entered into Purchase Agreement with the purchasers party thereto (effective 2026-05-18).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: the purchasers party thereto
  - Effective: 2026-05-18
  source text: On May 18, 2026, GeoVax Labs, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers party thereto, pursuant to which the Company agreed to issue and sell, in an unregistered private placement (the “Offering”), (i) pre-funded warrants
  evidence_url: https://www.sec.gov/Archives/edgar/data/832489/000143774926017809/0001437749-26-017809-index.htm
- Material Agreements
  GeoVax Labs, Inc. entered into Placement Agency Agreement with A.G.P./Alliance Global Partners (the “Placement Agent”) (effective 2026-05-18).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: A.G.P./Alliance Global Partners (the “Placement Agent”)
  - Effective: 2026-05-18
  source text: A.G.P./Alliance Global Partners (the “Placement Agent”) acted as the exclusive placement agent in connection with the Offering under a Placement Agency Agreement, dated as of May 18, 2026 (the “Placement Agency Agreement”) between the Company and the Placement Agent.
  evidence_url: https://www.sec.gov/Archives/edgar/data/832489/000143774926017809/0001437749-26-017809-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.